Prevalence of antibiotic resistance in multi-drug resistant coagulase-negative staphylococci isolated from invasive infection in very low birth weight neonates in two polish NICUs by Brzychczy-Włoch, Monika et al.
Brzychczy-Wloch et al. Annals of Clinical Microbiology and Antimicrobials 2013, 12:41
http://www.ann-clinmicrob.com/content/12/1/41RESEARCH Open AccessPrevalence of antibiotic resistance in multi-drug
resistant coagulase-negative staphylococci isolated
from invasive infection in very low birth weight
neonates in two Polish NICUs
Monika Brzychczy-Wloch1*, Maria Borszewska-Kornacka2, Ewa Gulczynska3, Jadwiga Wojkowska-Mach1,
Malgorzata Sulik4, Monika Grzebyk1, Malgorzata Luchter1, Piotr B Heczko1 and Malgorzata Bulanda5Abstract
Background: Multi-drug resistant coagulaso-negative staphylococci (CNS) have become an increasing problem in
nosocomial infections connected with the presence of medical devices. The paper aimed to analyze the prevalence
of antibiotic resistance in CNS isolated from invasive infection in very low birth weight (VLBW) neonates.
Methods: Continuous prospective target surveillance of infections was conducted in 2009 at two Polish NICUs that
participated in the Polish Neonatology Surveillance Network (PNSN). The study covered 386 neonates with VLBW
(≤1500 g), among which 262 cases of invasive infection were detected with predominance of CNS (123; 47%).
Altogether, 100 CNS strains were analyzed. The resistance phenotypes were determined according to EUCAST.
Resistance genes: mecA, ermA, ermB, ermC, msrA, aac(6')/aph(2''), ant(4')-Ia and aph(3')-IIIa were detected using
multiplex PCR.
Results: The most common species was S. epidermidis (63%), then S. haemolyticus (28%) and other CNS (9%).
Among S. epidermidis, 98% of isolates were resistant to methicillin, 90% to erythromycin, 39% to clindamycin, 95%
to gentamicin, 60% to amikacin, 36% to ofloxacin, 2% to tigecycline, 3% to linezolid and 13% to teicoplanin. Among
S. haemolyticus isolates, 100% were resistant to methicillin, erythromycin and gentamicin, 18% to clindamycin, 50%
to amikacin, 86% to ofloxacin, 14% to tigecycline and 4% to teicoplanin. No resistance to linezolid was detected for
S. haemolyticus isolates. Moreover, all isolates of S. epidermidis and S. haemolyticus were susceptible to vancomycin.
The mecA gene was detected in 98% of S. epidermidis isolates and all of S. haemolyticus ones. Among macrolide
resistance isolates, the ermC was most common in S. epidermidis (60%) while msrA was prevalent in S. haemolyticus
(93%). The ermC gene was indicated in all isolates with cMLSB, whereas mrsA was found in isolates with MSB
phenotype. Of the aminoglycoside resistance genes, aac(6')/aph(2'') were present alone in 83% of S. epidermidis,
whereas aac(6')/aph(2'') with aph(3')-IIIa were predominant in 84% of S. haemolyticus.
Conclusions: Knowing the epidemiology and antibiotic resistance of CNS isolated from invasive infection in VLBW
neonates is a key step in developing targeted prevention strategies and reducing antibiotic consumption.
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Coagulase-negative staphylococci (CNS) rank among
opportunistic pathogens being a frequent etiologic agent
of nosocomial infections connected with the presence of
medical devices. The cause for this should be sought in
the ability of CNS to create biofilm whereby they pose a
particular threat for people with valve prostheses and
the ones with implants or catheters [1]. A group which
is particularly susceptible to hospital infections are very
low birth weight (VLBW) neonates in which CNS are
identified as 48 up to 80% of all etiologic agents causing
late-onset diseases (LOD). The most frequently isolated
species are Staphylococcus epidermidis (58% – 76%) and
then Staphylococcus haemolyticus (14% – 32%) [2-4].
Medicating infections in neonates poses a big problem
as there is the need to use a therapy quickly. In the event
of infections caused by hospital pathogens, the empirical
treatment is adjusted based on information on drug-
resistance of the bacteria persisting in the ward. A high
percentage of S. epidermidis and S. haemolyticus isolates
coming from neonates are resistant to many antibiotics:
methicillin (86% – 100%), gentamicin (80% – 100%),
erythromycin (65% – 100%), oxacillin (92% – 100%),
or clindamycin (80% – 100%) [5-7].
The growing importance of coagulase-negative staphylo-
cocci, including multidrug-resistant strains, among other
etiologic agents of nosocomial infections, forcing researchers
to look for the most effective ways to combat these
pathogens. Therefore, the aim of the project was to
analyze the prevalence of antibiotic resistance in invasive
coagulase-negative staphylococci isolates derived from
very low birth weight neonates hospitalized in two Polish
Neonatal Intensive Care Units (NICUs).Methods
Continuous prospective target surveillance of infections
was conducted from 1.01.2009 to 31.12.2009 at two Polish
NICUs that participated in the Polish Neonatology Sur-
veillance Network (PNSN). The surveillance concerned
infants hospitalized at cooperating units whose birth
weight was ≤1500 grams (from birth to discharge, or
until the weight of 1800 grams or death). All cases of
infections were subject to registration, regardless of the
time of occurrence of the first symptoms as early-onset
infection (EOI) or late-onset infection (LOI). Case patients
were defined according to Gastmeier et al. [8] with
modifications as neonates with very low birth weight
(VLBW) when they had clinical signs of septicemia or
of pneumonia, as previously described [9]. The study
covered 386 VLBW neonates, among which 262 cases
of LOI infection were detected with predominance of
CNS (123; 47%) including blood stream infections (54
cases, 43.9%), pneumonia (58 cases, 47.2%) and others.(11 cases, 8.9%). Altogether, one hundred invasive coagu-
lase-negative staphylococci isolates were collected and
stored at the temperature of -80°C. Preliminary iden-
tification of species was performed using API Staph
(bioMerieux) and than multiplex PCR method according
to Pereira et al. [10].
Antibiotic susceptibility testing
To determine the drug-resistance phenotype, the Kirby-
Bauer disk diffusion method was used in which Müller-
Hinton 2 LAB-AGAR™ (Biocorp) and antibiotic disks
(Oxoid) were utilized: cefoxitin 30 μg, clindamycin 2 μg,
erythromycin 15 μg, tigecycline 15 μg, ofloxacin 5 μg,
gentamicin 10 μg, amikacin 30 μg, linezolid 10 μg and
the E-test method enabling determination of MIC (Minimal
Inhibitory Concentration) for teicoplanin and vancomycin
(bioMerieux). The results were interpreted according to
EUCAST (The European Committee on Antimicrobial
Susceptibility Testing) 2012 [10].
Polymerase chain reaction, PCR
To isolate DNA, the Genomic Mini Set (A&A Biotechnol-
ogy) was used according to the manufacturer’s protocol.
The presence of species-specific genes to S. haemolyticus
or S. epidermidis and methicillin-resistance mecA gene
was confirmed using multiplex PCR amplification accord-
ing to Pereira et al. [11] with specific primers (Genomed).
To detect genes coding the erythromycin-resistance,
the multiplex PCR reaction was conducted on ermA,
ermC, msrA genes and PCR on the ermB gene, according
to the procedure described by Zmantar et al. [12]. The
determination of aac(6′)/aph(2″), aph(3′)-IIIa and ant
(4′)-Ia genes coding the aminoglycoside-resistance was
conducted according to the procedure by Choi et al. [13].
The final pictures from electrophoresis were processed
using QuantityOne software, as well as GelDoc2000 device
(Bio-Rad, USA).
Results
The species identification with the multiplex PCR indi-
cated that 63% of the tested CNS isolates belonged to
S. epidermidis species, while 28% to S. haemolyticus
(Figure 1). The remaining 9% (n = 9) of isolates belonged
to other CNS species, including 4% (n = 4) S. warneri,
2% (n = 2) S. hominis, 2% (n = 2) S. xylosus and 1% (n = 1)
S. capitis.
A detailed analysis of drug resistance with the use of
phenotypic and genotypic methods was carried out for
isolates of the species S. epidermidis (n = 63) and S.
haemolyticus (n = 28). Among the isolates tested, there
was a very high percentage of multi-drug resistant
strains. Among S. epidermidis, 98% (n = 62) of isolates
were resistant to methicillin, 90% (n = 57) to erythromycin,
39% (n = 25) to clindamycin, 95% (n = 60) to gentamicin,
Figure 1 An example of the outcome of the multiplex PCR reaction for determining the species of Staphylococcus aureus (108 bp),
Staphylococcus epidermidis (124 bp), Staphylococcus haemolyticus (271 bp) and for detecting the presence of mecA gene (154 bp).
Legend: Lanes 1 – 10 studied samples; 11 – positive control reference S. aureus ATCC 33592; 2 – positive control reference S. epidermidis ATCC
700296; 13 – positive control reference S. haemolyticus ATCC 29970, 14 – negative control; 15 – marker (Eurx Perfect TM 100 bp DNA Ladder).
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(n = 1) to tigecycline, 3% (n = 2) to linezolid and 13% (n = 8)
to teicoplanin. Among S. haemolyticus isolates, 100%
(n = 28) were resistant to methicillin, erythromycin and
gentamicin, 18% (n = 5) to clindamycin, 50% (n = 14) to
amikacin, 86% (n = 24) to ofloxacin, 14% (n = 4) to tige-
cycline and 4% (n = 1) to teicoplanin. No resistance to
linezolid was detected for S. haemolyticus isolates. More-
over, all isolates of S. epidermidis and S. haemolyticus were
susceptible to vancomycin (Figure 2).
Using E-test, the values for MIC50 and MIC90 were
determined for teicoplanin and vancomycin. For S. epi-
dermidis, MIC50 and MIC90 for teicoplanin was equal
to 2 and 6, respectively, while for vancomycin, it was 2 and
3. For S. haemolyticus, MIC50 and MIC90 for teicoplanin
was equal to 2 and 3, respectively, and for vancomycin, it
was 2 and 3.
Among S. epidermidis isolates resistant to macrolides
(n = 57), the cMLSB and MSB phenotypes were most
common, and performed in 43% (n = 25) and 40% (n = 23)Figure 2 The percentage of isolates of the species S. epidermidis andof isolates, respectively. While the iMLSB phenotype
was present in 16% (n = 9) of S. epidermidis. The MSB
phenotype was predominant among S. haemolyticus
`isolates (n = 28), and appeared in 82% of isolates (n = 23),
whereas cMLSB phenotype was detected in 18% of the
isolates (n = 5). In the case of S. heamolyticus, the MSB
phenotype was not detected (Figure 3).
The presence of mecA gene was confirmed with the
multiplex PCR method in 62 S. epidermidis (98%) isolates
and in 28 isolates of the species S. haemolyticus (100%)
(Figure 1).
The ermC gene was predominant in S. epidermidis iso-
lates (n = 34; 60%), while in S. haemolyticus was present
only in 2 isolates (7%). On the other hand, msrA gene was
prevalent in S. haemolyticus isolates (n = 26; 93%), while in
S. epidermidis it was much less frequent (n = 23; 40%). It
is noteworthy to remark that one of the S. haemolyticus
isolates possessed both msrA and ermC genes simultan-
eously. The presence of ermA oraz ermB genes was not
demonstrated in the studied isolate pool (Figure 4).S. haemolyticus, resistant to the studied antibiotics.
Figure 3 The percentage of isolates of the species S. epidermidis
and S. haemolyticus with macrolide resistance phenotype cMLSB,
iMLSB and MSB.
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and iMLSB resistance phenotype, possessed ermC gene
(n = 34; 60%). While five S. haemolyticus isolates of cMLSB
resistance phenotype demonstarted the presence of various
genes, including three with msrA gene, in the second one
ermC and in the remaining one of ermC and msrA genes
at the same time. In all S. epidermidis isolates (n = 23;
100%) and S. haemoltyticus (n = 23; 100%) of MSB pheno-
type, gene msrA was present.
Among the genes coding aminoglycoside resistance,
aac(6′)/aph(2″) gene was the most frequent, and the
genes more rare were aph(3′)-Ia and aph(3′)-IIIa. In S.
epidermidis, isolates with the aac(6′)/aph(2″) gene were
prevalent (n = 49; 83%), while in S. haemolyticus, the aac
(6′)/aph(2″) was the most frequent together with aph
(3′)-IIIa (n = 22; 84%) (Figures 5 and 6).
Discussion
Infections caused by coagulase-negative staphylococci
are among the most common causes of death among
infants with very low birth weight [14]. This is due to
the fact that staphylococcal biofilm can be formed on
biomaterials, from which are made various types ofFigure 4 An example of the outcome of the multiplex PCR reaction fo
(139 bp), ermC (190 bp) and msrA (163 bp). Legend: Lane 1 –marker (Eu
18 – positive control reference msrA W2/28; 19 – positive control referencedevices used in patients chronically hospitalized. Bacteria
growing in biofilm are characterized by an increased
resistance to the host immune system and antibiotic
use, making it more difficult and significantly extending
the patient’s hospitalization [1,15].
The researched CNS isolates demonstrated multi-drug
resistance. The studied S. epidermidis isolates and S.
haemolyticus were resistant to methicillin, in 98% and
100%, respectively, as well as to the majority of the
remaining antibiotics that were studied. These results
are concurrent with the literature data where for CNS
isolated from neonatal infections the percentage of
methicillin-resistant strains (methicillin-resistant coagulase-
negative staphylococci, MRCNS) was in the range of
86-100%, and, moreover, these bacteria was connected
with multiple resistance to other antibiotics [6,7].
Investigation of the mecA gene in CNS using the PCR
technique is nowadays regarded as the gold standard with
a view to determining methicillin resistance [11]. In our
study, meticillin-resistance phenotype for all the researched
strains was confirmed by the detection of the mecA gene.
Similar results were described by other authors [11].
The group of isolates was characterized by high erythro-
mycin resistance which was 84% for isolates of S. epider-
midis and 100% for S. haemolyticus. The results obtained
are similar to those of Bialkowska-Hobrzanska et al. where
100% of isolates S. epidermidis and 92% of S. haemolyticus
isolated from neonates were erythromycin-resistant [16],
as well as similar to the data obtained by Abd El Hafez
et al. where the erythromycin resistance for isolates of
S. epidermidis coming from neonates was 86% [6].
Clindamycin resistance was demonstrated in 26% of
isolates of S. epidermidis and 28% of isolates of S. hae-
molyticus. The determined percentage of clindamycin
resistance was significantly lower than that described by
Bialkowska-Hobrzanska et al. where for S. epidermidis
it was equal to 92%, and for S. haemolyticus 85% [16];
similarly, Abd El Hafez et al. demonstated 75.9% of iso-
lates of S. epidermidis as resistant [6], and higher thanr determining the genes coding macrolide resistance ermA
rx Perfect TM 100 bp DNA Ladder ); 2 – 17 studied samples;
ermC W2/55; 20 – negative control.
Figure 5 An example of the outcome of the multiplex PCR reaction for determining the genes coding aminoglycoside resistance aac
(6′)/aph(2″) (491 bp), aph(3′)-IIIa (292 bp), ant(4′)-Ia (135 bp). Legend: lanes 1 – 16 studied samples; 17 – positive control reference aac(6')/aph
(2") and aph(3')-IIIa W2/60; 18 – positive control reference aac(6')/aph(2") and ant(4')-Ia W2/9, 19 – negative control, 20 – marker (Eurx Perfect TM
100 bp DNA Ladder).
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CNS altogether [17].
Among the S. epidermidis strains that were macrolide-
resistant, the cMLSB phenotype constituted 43% and
MSB 40% whereas in S. haemolyticus the most frequently
detected MSB phenotype occurred in 82% of isolates.
Similar results were described by Gheradi et al. who
researched CNS coming from hospital infections where
38% of isolates of S. epidermidis and 80% of isolates of
S. haemolyticus had the MSB phenotype and 28.5% of
isolates of S. epidermidis had the cMLSB phenotype [18].
However, Gatermann et al. clearly described a lower per-
centage of isolates of S. haemolyticus with the phenotype
MSB equal to 30.2% [19]. For the isolates of S. epidermidis
researched on with the cMLSB and iMLSB phenotypes, the
occurrence of the ermC gene was demonstrated and with
the MSB phenotype, the msrA gene. However, 3 out of 5 S.
haemolyticus isolates with the cMLSB phenotype had the
msrA gene, but did not have the emrC gene. Moreover,
in the group of isolates of S. haemolyticus with the MSBFigure 6 Percentage of aminoglycoside resistance genes: aac(6′)/aph(
and S. haemolyticus.resistance phenotype, it was demonstrated that one isolate
had no msrA gene. Probably, those isolates had other
genes coding the erythromycin resistance. The recorded
lack of ermA and ermB genes among the isolates
researched on is in conformity with the results of other
scientists researching CNS who indicated the presence
of these genes only as high as 1.8% – 7.2% for ermA
and below 1% for ermB [20].
The gentamicin resistance was 93% for S. epidermidis,
100% for S. haemolyticus and it was higher than quoted
in the literature for S. epidermidis 69.2 – 89.5% [17,21]
and for CNS altogether 85% except the results obtained
by Bialkowska-Hobrzanska et al. where for both S. epider-
midis and S. haemolyticus the resistance equaled 100%
[16]. In the case of amikacin, the resistant strains of S.
epidermidis constituted 51% of those studied, whereas
31% of S. haemolyticus isolates were amikacin-resistant.
From among the genes coding aminoglycoside resist-
ance, the most frequently identified gene was aac(6′)/aph
(2″) which both in S. epidermidis and S. haemolyticus2″), aph(3′)-IIIa, ant(4′)-Ia in isolates of the species S. epidermidis
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isolated from neonates researched by Klingenberg et al.
69.4% of subjects had the aac(6′)/aph(2″) gene [21].
Also, among isolates coming from various groups of
patients with hospital infections, the main role in coding
aminoglycoside resistance had the aac(6′)/aph(2″) gene
occurring in 70 – 90% of CNS isolates [13]. Characteristic
of S. haemolyticus was the presence, along with the aac
(6′)/aph(2″) gene, of another gene coding aminoglycoside
resistance, meaning aph(3′)-IIIa (78%). The comparison of
resistance obtained by means of phenotypic methods
and genotypic methods enabled observing certain dis-
crepancies. Similarly, Choi et al. observed that only in ca.
50% of CNS isolates there existed a correlation between
the phenotype of amikacin resistance and the genotype
[13]. According to recommendations of EUCAST (2012)
[10], the isolates demonstrating gentamicin resistance
are to be treated as having a general aminoglycoside
resistance with the exception of streptomycin, as this
one is most probably coded by the aac(6′)/aph(2″)
gene the product of which modifies antibiotics such as
gentamicin, kanamycin, tobramycin and amikacin [22].
The phenotype of gentamicin resistance, despite the
missing aac(6′)/aph(2″) gene, may be caused by the
presence of other genes coding aminoglycoside resistance
which were not determined in the method used. The
observed lack of aminoglycoside resistance phenotype
in 3 isolates of S. epidermidis having the aac(6′)/aph
(2″) gene probably signifies the loss of functionality of
that gene.
The determination of glycopeptide resistance constitutes
a significant part of the characteristics of the CNS isolates
as these antibiotics are most frequently administered in
the empirical treatment of MRCNS infections in VLBW
neonates. In the pool of the studied CNS isolates, all of
them were susceptible to vancomycin, which is concurrent
with observations made by other researchers dealing with
CNS isolated from neonatal infections [5,6,17]. Neverthe-
less, the MIC value for individual isolates achieved the
point of 4 mg/L which is the cut-off point for resistant
isolates [10]. The fact of obtaining vancomycin resistance
by coagulase-negative staphylococci is confirmed by cases
of vancomycin resistance among CNS isolates isolated
from infections in various groups of patients, which
were recorded by several different research groups
[23]. In the case of teicoplanin in the pool of isolates
researched, resistance was proven for 13% of S. epider-
midis and 3% of S. haemolyticus, which constitutes a
conformation of increasing glycopeptide antibiotic re-
sistance. Similar results were obtained by Trueba et al.
where 30.4% of isolates of S. epidermidis and 35.7% of
S. haemolyticus turned out to be teicoplanin-resistant
[24] and Kristyof et al. where 32% of S. haemolyticus
demonstrated resistance [25].Conclusions
The multi-drug resistance profiles obtained for isolates of
coagulase-negative staphylococci isolated from infections of
VLBW neonates hospitalized in NICUs indicate that there
is a need to constantly monitor the resistance of these
strains. At present, the drugs of choice are vancomycin and
teicoplanin with the reservation that a quick selection of
teicoplanin-resistant isolates of CNS is possible.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MBW designed the study, analyzed and interpreted the data, financially
supported the study and wrote the manuscript; MBK and EG collected the
data about VLBW neonates; MS collected the CNS isolates; MG and ML
performed the molecular studies; JWM and PBH designed the Polish
Neonatology Surveillance Network (PNSN); MB prepared the literature.
All authors read and approved the final manuscript.
Acknowledgements
The study was approved by Jagiellonian University Bioethical Committee
decision no. KBET/94/B/2009. This study was supported by a grant from the
National Science Centre no. N N401 615 340.
Author details
1Department of Bacteriology, Microbial Ecology and Parasitology, Chair of
Microbiology, Jagiellonian University Medical College, Czysta Street 18,
31-121, Krakow, Poland. 2Neonatal and Intensive Care Department Medical
University of Warsaw, Warsaw, Poland. 3Polish Mother’s Memorial Hospital,
Lodz, Poland. 4Duchess Anna Mazowiecka Teaching Hospital, Warsaw,
Poland. 5Department of Epidemiology of Infection, Chair of Microbiology,
Jagiellonian University Medical College, Krakow, Poland.
Received: 17 October 2013 Accepted: 15 December 2013
Published: 20 December 2013
References
1. Otto M: Staphylococcus epidermidis – the ‘accidental’ pathogen. Nat Rev
Microbiol 2009, 7:555–567.
2. Gheibi S, Fakoor Z, Karamyyar M, Khashabi J, Ilkhanizadeh B, Farzin Asghari-Sana
F, Mahmoodzadeh H, Majlesi A: Coagulase Negative Staphylococcus; the Most
Common Cause of Neonatal Septicemia in Urmia, Iran. Iran J Pediatr 2008,
18:237–243.
3. Hira V, Sluijter M, Estevão S, Horst-Kreft D, Ott A, De Groot R, Hermans PW,
Kornelisse RF: Clinical and molecular epidemiologic characteristics of
coagulase-negative staphylococcal bloodstream infections in intensive
care neonates. Pediatr Infect Dis J 2007, 26:607–612.
4. Dimitriou G, Fouzas S, Giormezis N, Giannakopoulos I, Tzifas S, Foka A,
Anastassiou DE, Spiliopoulou I, Mantagos S: Clinical and microbiological
profile of persistent coagulase-negative staphylococcal bacteraemia in
neonates. Clin Microbiol Infect 2011, 17:1684–1690.
5. Villari P, Sarnataro C, Iacuzio L: Molecular Epidemiology of Staphylococcus
epidermidis in a Neonatal Intensive Care Unit over a Three-Year Period.
J Clin Microbiol 2000, 38:1740–1746.
6. Abd El Hafez M, Khalaf NG, El Ahmady M, Abd El Aziz A, Hashim Ael G:
An outbreak of methicillin resistant Staphylococcus epidermidis among
neonates in a hospital in Saudi Arabia. J Infect Dev Ctries 2011, 5:692–699.
7. Qu Y, Daley A, Istivan T, Garland S, Deighton M: Antibiotic susceptibility of
coagulase -negative staphylococci isolated from very low birth weight
babies: comprehensive comparisons of bacteria at different stages of
biofilm formation. Ann Clin Microbiol Antimicrob 2010, 9:16.
8. Gastmeier P, Geffers C, Schwab F, Fitzner J, Oblader M, Rüden H:
Development of a surveillance system for nosocomial infections: the
component for neonatal intensive care in Germany. J Hosp Infect 2004,
57:126–131.
9. Wojkowska-Mach J, Borszewska-Kornacka M, Domanska J, Gadzinowski J,
Gulczynska E, Helwich E, Kordek A, Pawlik D, Szczapa J, Klamka J, Heczko PB:
Brzychczy-Wloch et al. Annals of Clinical Microbiology and Antimicrobials 2013, 12:41 Page 7 of 7
http://www.ann-clinmicrob.com/content/12/1/41Early-onset infections of very-low-birth-weight infants in Polish neonatal
intensive care units. Pediatr Infect Dis J 2012, 31:691–695.
10. EUCAST - European Committee on Antimicrobial Susceptibility Testing: Version
2.0, valid from 2012-01-01; 2012. http://www.eucast.org/fileadmin/src/media/PDFs/
EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v_2.0_120101.pdf.
11. Pereira EM, Schuenck RP, Malvar KL, Iorio NL, Matos PD, Olendzki AN,
Oelemann WM, Dos Santos KR: Staphylococcus aureus, Staphylococcus
epidermidis and Staphylococcus haemolyticus: methicillin-resistant isolates
are detected directly in blood cultures by multiplex PCR. Microbiol Res
2010, 165:243–249.
12. Zmantar T, Chaieb K, Ben Abdallah F, Ben Kahla-Nakbi A, Ben Hassen A,
Mahdouani K, Bakhrouf A: Multiplex PCR detection of the antibiotic resistance
genes in Staphylococcus aureus strains isolated from auricular infections.
Folia Microbiol 2008, 53:35–362.
13. Choi SM, Kim SH, Kim HJ, Lee DG, Choi JH, Yoo JH, Kang JH, Shin WS, Kang MW:
Multiplex PCR for the detection of genes encoding aminoglycoside
modifying enzymes and methicillin resistance among Staphylococcus
species. J Korean Med Sci 2003, 18:631–636.
14. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA,
Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB,
Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK: Late-onset
sepsis in very low birth weight neonates: the experience of the NICHD
Neonatal Research Network. Pediatrics 2002, 110:285–291.
15. Crossley K, Jefferson K, Archer G, Fowler V: Saphylococci In Human Disease.
Oxford: Wiley- Blackwell; 2009.
16. Bialkowska-Hobrzanska H, Jaskot D, Hammerberg J: Molecular
characterization of the coagulase-negative staphylococcal surface flora
of premature neonates. J Gen Microbiol 1993, 139:2939–2944.
17. van den Hoogen A, Gerards L, Verboon-Maciolek M, Fleer A, Krediet T:
Long-term trends in the epidemiology of neonatal sepsis and antibiotic
susceptibility of causative agents. Neonatol 2010, 97:22–28.
18. Gherardi G, De Florio L, Lorino G, Fico L, Dicuonzo G: Macrolide resistance
genotypes and phenotypes among erythromycin-resistant clinical isolates
of Staphylococcus aureus and coagulase-negative staphylococci, Italy.
FEMS Immunol Med Microbiol 2009, 55:62–67.
19. Gatermann SG, Koschinski T, Friedrich S: Distribution and expression of
macrolide resistance genes in coagulase-negative staphylococci.
Clin Microbiol Infect 2007, 13:777–781.
20. Bouchami O, Achour W, Mekni MA, Rolo J, Ben HA: Antibiotic resistance
and molecular characterization of clinical isolates of methicillin-resistant
coagulase-negative staphylococci isolated from bacteremic patients in
oncohematology. Folia Microbiol 2011, 56:122–130.
21. Klingenberg C, Sundsfjord A, Rønnestad A, Mikalsen J, Gaustad P, Flaegstad
T: Phenotypic and genotypic aminoglycoside resistance in blood culture
isolates of coagulase-negative staphylococci from a single neonatal in-
tensive care unit, 1989–2000. J Antimicrob Chemother 2004, 54:889–896.
22. Liakopoulos A, Foka A, Vourli S, Zerva L, Tsiapara F, Protonotariou E, Dailiana
Z, Economou M, Papoutsidou E, Koutsia-Carouzou C, Anastassiou ED, Diza E,
Zintzaras E, Spiliopoulou I, Petinaki E: Aminoglycoside-resistant staphylococci
in Greece: prevalence and resistance mechanisms. Eur J Clin Microbiol Infect
Dis 2011, 30:701–705.
23. Juárez-Verdayes MA, Reyes-López MA, Cancino-Díaz ME, Muñoz-Salas S,
Rodríguez-Martínez S, de la Serna FJ, Hernández-Rodríguez CH, Cancino-Díaz JC:
Isolation, vancomycin resistance and biofilm production of Staphylococcus
epidermidis from patients with conjunctivitis, corneal ulcers, and endophthal-
mitis. Rev Latinoam Microbiol 2006, 48:238–246.
24. Trueba F, Garrabe E, Hadef R, Fabre R, Didier CJ, Tsvetkova K, Chesneau O: High
prevalence of teicoplanin resistance among Staphylococcus epidermidis
strains in a 5-year retrospective study. J Clin Microbiol 2006, 44:1922–1923.
25. Kristóf K, Kocsis E, Szabó D, Kardos S, Cser V, Nagy K, Hermann P, Rozgonyi F:
Significance of methicillin-teicoplanin resistant Staphylococcus haemolyticus
in bloodstream infections in patients of the Semmelweis University
hospitals in Hungary. Eur J Clin Microbiol Infect Dis 2011, 30:691–699.
doi:10.1186/1476-0711-12-41
Cite this article as: Brzychczy-Wloch et al.: Prevalence of antibiotic
resistance in multi-drug resistant coagulase-negative staphylococci isolated
from invasive infection in very low birth weight neonates in two Polish
NICUs. Annals of Clinical Microbiology and Antimicrobials 2013 12:41.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
